Search

everythinglearnresearchcommunity

for

Search:↓

Fibroblast Growth Factor-9 (FGF-9) can help improve heart function in diabetic mice after a heart attack by reducing inflammation and harmful changes to the heart's structure.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

miR-486 may help prevent hair loss in alopecia areata.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Interleukin‐1 α reduces androgen receptor levels and increases certain cytokines in human scalp cells.

MCP@G improves diabetic wound healing by reducing stress and promoting tissue repair.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

QLT0267 stops hair follicle cell growth and movement.

miRNA-24 affects goat coat color by controlling proteins involved in pigment production.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

WIF1 helps keep skin stem cells inactive to prevent excessive cell growth.

iNKT cells help develop and maintain healthy skin in young mice.

A patient developed a blister at the injection site after hepatitis C treatment.

BMS-470539 reduces skin fibrosis and inflammation.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Platelet-released growth factors can reduce inflammation in joint disease.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Psoriasis may be chronic because it lacks certain immune system controls that prevent overreaction.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Ferroportin in macrophages is crucial for hair growth and skin healing by managing iron distribution.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Decreasing MIG6 can increase the movement and invasiveness of MEK-inhibited mutant NRAS melanoma, particularly when stimulated by EGF.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

PDRN may reduce inflammation and complications in revision rhinoplasty for patients with high fibrinogen levels.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.